Lin Dang

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients.

Clinical efficacy, drug retention and recurrence of ixekizumab across psoriasis severities: a multicenter retrospective analysis of 354 patients.

Journal: The Journal of dermatological treatment
Published: October 01, 2025

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis.

The Psoriatic Disease Assessment Index (PSODAI) Score to Evaluate Systemic Involvement of Psoriasis.

Journal: Psoriasis (Auckland, N.Z.)
Published: June 21, 2025

Epidemiological Profile of Psoriasis and Linked Comorbidities in Chinese Population at Shenzhen: A Cross-Sectional Study.

Epidemiological Profile of Psoriasis and Linked Comorbidities in Chinese Population at Shenzhen: A Cross-Sectional Study.

Journal: Health science reports
Published: May 10, 2024

The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study.

The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study.

Journal: Drug safety
Published: March 18, 2024

ACOT7 positively regulated by CREB1 promotes the progression of cutaneous melanoma.

ACOT7 positively regulated by CREB1 promotes the progression of cutaneous melanoma.

Journal: Acta histochemica
Published: February 09, 2024

Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study.

Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study.

Journal: Dermatology and therapy
Published: December 14, 2023

A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis.

A large-scale retrospective study in China explores risk factors for disease severity in plaque psoriasis.

Journal: Scientific reports
Published: December 11, 2023

LncRNA RP11-818O24.3 promotes hair-follicle recovery via FGF2-PI3K/Akt signal pathway.

LncRNA RP11-818O24.3 promotes hair-follicle recovery via FGF2-PI3K/Akt signal pathway.

Journal: Cytotechnology
Published: June 28, 2023

Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study.

Quality of Life Benefit and Clinical Predictors of Complete Skin Clearance in Psoriasis: A Multicenter, Prospective, Real-World Study.

Journal: Dermatology (Basel, Switzerland)
Published: February 04, 2023

ANRIL polymorphisms in psoriasis vulgaris patients in northern China

ANRIL polymorphisms in psoriasis vulgaris patients in northern China

Journal: European journal of dermatology : EJD
Published: July 22, 2022

Downregulation of sperm-associated antigen 5 inhibits melanoma progression by regulating forkhead box protein M1/A disintegrin and metalloproteinase 17/NOTCH1 signaling.

Downregulation of sperm-associated antigen 5 inhibits melanoma progression by regulating forkhead box protein M1/A disintegrin and metalloproteinase 17/NOTCH1 signaling.

Journal: Bioengineered
Published: February 09, 2022

Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.

Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.

Journal: Bioengineered
Published: June 02, 2021
Showing 1-12 of 17

Last Updated: 09/26/2026